CYVNY
PINK Ceryvyn Therapeutics Limited Sponsored ADR$0.0350 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0350, and at the day’s high of $0.0350
- YTD change
- +103.49%
- vs 20-day SMA
- +44.14%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.02 (+103.49%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 98.9% away from all-time highs of $3.1700
- CYVNY is up 103% since the beginning of the year
- CYVNY is up 103% over the past 12 months
- CYVNY is up 59% over the past 1 month
CYVNY reads n/a: the 12-month move is +103.5%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +49.57%
- vs 8-day SMA
- +49.89%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Ceryvyn Therapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and research of novel therapeutic products based on targeting Vascular Endothelial Growth Factors. It operates through the United States and Australia geographical segments. The company was founded by Dr. Megan Baldwin on October 17, 1984, and is headquartered in Melbourne, Australia.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
